MedTrace Logo

Opioid Sparing Potential of Light-Induced Analgesia

NCT03890419 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2021-10-13

Study results available
· View outcomes & findings →

Summary

This is a pilot trial testing the potential opioid-sparing analgesic effect of a novel non-pharmacological treatment using visualized light spectrums. Preclinical findings have shown such treatments to alter pain perception.

Conditions

Interventions

DEVICE

Green light

Green light exposure

DEVICE

Clear light

Full spectrum light exposure

DEVICE

Blue Light

Blue light exposure

Sponsors & Collaborators

Principal Investigators

  • Padma Gulur, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03890419 on ClinicalTrials.gov